Compare Chubb Ltd (CB) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chubb Ltd vs Moderna, Inc. — how do they compare? Chubb Ltd trades at $346 (market cap $133.90B), while Moderna, Inc. trades at $60.77 (market cap $24.18B). The key difference: Chubb Ltd is far larger — about 5.5× Moderna, Inc.'s market cap, and Chubb Ltd pays a 1.18% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| CB | MRNA | |
|---|---|---|
Market Cap | $133.90B | $24.18B |
Sector | Financials | Health |
52-Week High | $363.50 | $81.80 |
52-Week Low | $268.20 | $22.36 |
Enterprise Value | $154.74B | $20.33B |
Dividend Yield | 1.18% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Chubb Ltd
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
